Impli has developed a biosensing platform that utilizes subdermal sensors and NFC technology to provide real-time monitoring of hormone levels critical for in vitro fertilization (IVF). This technology reduces the need for frequent blood draws, enabling fertility specialists to optimize treatment protocols and improve the chances of successful pregnancies.
Funding
Funding not disclosed
Founders
Product
Problem
In vitro fertilization (IVF) requires frequent hormone level monitoring via blood draws, which is invasive, inconvenient, and provides only intermittent data points. This can lead to suboptimal treatment protocols and potentially reduce the likelihood of successful pregnancies.
Solution
Impli offers a real-time hormone monitoring platform for IVF patients, utilizing subdermal biosensors and NFC technology to continuously track hormone levels. The implantable sensor eliminates the need for frequent blood draws, providing fertility specialists with a comprehensive hormonal profile of the patient. This continuous data stream enables clinicians to optimize medication dosages and timing, improving the chances of successful fertilization and implantation. The platform also aids in the early identification of potential issues like Ovarian Hyperstimulation Syndrome (OHSS), allowing for timely interventions and personalized care.
Target Audience
The primary target audience includes fertility specialists and IVF clinics seeking to improve treatment outcomes and patient experience through continuous hormone monitoring.
Features
- Subdermal biosensors for continuous, real-time monitoring of key hormone levels
- NFC technology for wireless data transmission from the sensor
- Minimally invasive implantation procedure
- Continuous data stream enabling personalized treatment adjustments
- Early detection capabilities for potential complications like OHSS
- Data-driven insights to assist fertility specialists in selecting the best treatment
- Optimized medication dosages and timing for improved fertilization and implantation rates